These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8480502)

  • 21. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale for calcium entry-blocking drugs in systemic hypertension complicated by coronary artery disease.
    O'Rourke RA
    Am J Cardiol; 1985 Dec; 56(16):34H-40H. PubMed ID: 2866705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraoperative administration of clevidipine to prevent vasospasm after radial and internal mammary artery grafts during coronary artery bypass grafting.
    Patel M; Meyer T; Tharakan A; Tobias JD
    Am J Ther; 2012 May; 19(3):e114-7. PubMed ID: 20634670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Position of calcium antagonists in antihypertensive therapy.
    Bühler FR; Bolli P; Erne P; Kiowski W; Müller FB; Hulthén UL; Ji BH
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S21-7. PubMed ID: 2412007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of intravenous nifedipine and sodium nitroprusside for treatment of acute hypertension after cardiac surgery.
    Bertolissi M; De Monte A; Giordano F
    Minerva Anestesiol; 1998; 64(7-8):321-8. PubMed ID: 9796241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of intravenous dihydropyridine calcium channel blockers in the perioperative management of patients undergoing coronary artery bypass surgery.
    Khoynezhad A; Dobesh PP; Stacy Z; Jalali Z
    Curr Vasc Pharmacol; 2008 Jul; 6(3):186-94. PubMed ID: 18673158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spasm in Arterial Grafts in Coronary Artery Bypass Grafting Surgery.
    He GW; Taggart DP
    Ann Thorac Surg; 2016 Mar; 101(3):1222-9. PubMed ID: 26588865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical considerations for the use of intravenous nicardipine in the treatment of postoperative hypertension.
    Kaplan JA
    Am Heart J; 1990 Feb; 119(2 Pt 2):443-6. PubMed ID: 2405614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous nicardipine in the treatment of postoperative arterial hypertension.
    Vincent JL; Berlot G; Preiser JC; Engelman E; Dereume JP; Khan RJ
    J Cardiothorac Vasc Anesth; 1997 Apr; 11(2):160-4. PubMed ID: 9105985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydropyridine calcium channel antagonists in the management of hypertension.
    Epstein BJ; Vogel K; Palmer BF
    Drugs; 2007; 67(9):1309-27. PubMed ID: 17547473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological basis for use of calcium antagonists in hypertension.
    Scriabine A; Kazda S
    Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium-channel blockers for combined systemic hypertension and myocardial ischemia.
    Frishman WH; Charlap S
    Circulation; 1987 Jun; 75(6 Pt 2):V154-62. PubMed ID: 3552312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial factors and microvascular hypertensive disease.
    Rizzoni D; Agabiti-Rosei E
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S15-8. PubMed ID: 11811369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium overload--an important cellular mechanism in hypertension and arteriosclerosis.
    Fleckenstein-Grün G; Frey M; Thimm F; Hofgärtner W; Fleckenstein A
    Drugs; 1992; 44 Suppl 1():23-30. PubMed ID: 1283581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of calcium antagonists to treat intra-operative hypertension--evaluation of efficacy and safety of a new dihydropyridine derivative, intravenous isradipine, during abdominal surgery.
    Edouard A; Dartayet B; Ruegg C; Samii K
    Eur J Anaesthesiol; 1991 Sep; 8(5):351-8. PubMed ID: 1834462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental basis of the long-term therapy of arterial hypertension with calcium antagonists.
    Fleckenstein A; Frey M; Zorn J; Fleckenstein-Grün G
    Am J Cardiol; 1985 Dec; 56(16):3H-14H. PubMed ID: 2416214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to use calcium antagonists in hypertension: putting the JNC-VI guidelines into practice. Joint National Committee for the Prevention, Detection, Evaluation and Treatment of High Blood Pressure.
    Singh V; Christiana J; Frishman WH
    Drugs; 1999 Oct; 58(4):579-87. PubMed ID: 10551431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological basis for use of calcium channel antagonists in hypertension.
    Scriabine A; Kazda S; Garthoff B; Nickerson PA
    Angiology; 1988 Jan; 39(1 Pt 2):94-9. PubMed ID: 2449099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.